The sole Food and Drug Administration‐approved device for transcatheter closure of the patent arterial duct in premature infants is indicated for patent ductus arteriosus (PDAs) ≤ 4 mm in diameter. We report a… Click to show full abstract
The sole Food and Drug Administration‐approved device for transcatheter closure of the patent arterial duct in premature infants is indicated for patent ductus arteriosus (PDAs) ≤ 4 mm in diameter. We report a two‐center experience with transcatheter closure of large PDAs (>4 mm) in infants weighing <2.5 kg using the Microvascular Plug 7Q (MVP‐7Q) device.
Keywords:
ductus arteriosus;
transcatheter;
transcatheter closure;
patent ductus
Journal Title: Catheterization and Cardiovascular Interventions
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Catheterization and Cardiovascular Interventions
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!